SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-24-000035
Filing Date
2024-02-02
Accepted
2024-02-02 17:09:20
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706911749.html 4  
1 FORM 4 wk-form4_1706911749.xml 4 8402
  Complete submission text file 0001847903-24-000035.txt   10033
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
HUSSAIN IQBAL J (Reporting) CIK: 0001862050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 24592639